Jaya Biosciences
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
136 E Rosemary Ste 100, Chapel Hill, Nor...Website
www.jayabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Jaya Biosciences
Jaya Biosciences is a privately held pre-clinical stage life sciences company focused on developing CNS-directed gene therapies for genetically defined neurodegenerative diseases, such as Alzheimer's, Parkinson's, and frontotemporal dementia. Their lead therapy, JB111, is an experimental AAV9-mediated gene therapy aimed at treating Alzheimer's disease associated with specific genetic mutations. The company is committed to addressing unmet needs in neurodegeneration and has received patents in multiple countries to protect its innovative treatment methods. Jaya Biosciences targets clients in the healthcare and pharmaceutical sectors, particularly those involved in neurological disease research and treatment.Explore more
Popular SearchesJaya BiosciencesJaya Biosciences IncSIC Code 87,873NAICS Code 54,541Show moreJaya Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Jaya Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Jaya Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Jaya Biosciences
Check if Jaya Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Jaya Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Jaya Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Jaya Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once Jaya Biosciences has new funding data
Product Launch: Get notified when Jaya Biosciences launches new products
Recommended Actions
Find VP level buyers at Jaya Biosciences
Find 2 more new buyers
Compare Similar Companies to Jaya Biosciences
Compare insights from companies similar to Jaya Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Jaya Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Jaya Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Jaya Biosciences.
Jaya Biosciences Tech Stack
A closer look at the technologies used by Jaya Biosciences
Jaya Biosciences News & Media
Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s, Further Strengthening its Global Intellectual Property Portfolio
- Patent allowances in Japan, China and Singapore support Jaya Biosciences’ commitment to addressing unmet needs in neurodegeneration in global markets - - Patent allowances in Japan, China and Singapore support Jaya Biosciences’ commitment to addressing unmet needs in neurodegeneration in global markets -Jaya Biosciences Presents Updated Preclinical Data in Alzheimer’s Disease at the 45th SIMD Annual Meeting
- Study results confirm potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s disease - - Study results confirm potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s disease -Jaya Biosciences Presents New Paradigm for the Treatment of Alzheimer’s Disease at the 23ʳᵈ Annual Needham Virtual Healthcare Conference
- Data presented highlight the potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s - - Data presented highlight the potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s -
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Jaya Biosciences
Sign Up For FreeTo access detailed company insights
Jaya Biosciences is a privately held pre-clinical stage life sciences company focused on developing CNS-directed gene therapies for genetically defined neurodegenerative diseases, such as Alzheimer's, Parkinson's, and frontotemporal dementia. Their lead therapy, JB111, is an experimental AAV9-mediated gene therapy aimed at treating Alzheimer's dise... Read More
